DE69711588D1 - Nimesulid enthaltende pharmazeutische zubereitung zur topischen anwendung - Google Patents

Nimesulid enthaltende pharmazeutische zubereitung zur topischen anwendung

Info

Publication number
DE69711588D1
DE69711588D1 DE69711588T DE69711588T DE69711588D1 DE 69711588 D1 DE69711588 D1 DE 69711588D1 DE 69711588 T DE69711588 T DE 69711588T DE 69711588 T DE69711588 T DE 69711588T DE 69711588 D1 DE69711588 D1 DE 69711588D1
Authority
DE
Germany
Prior art keywords
pct
nimesulide
pharmaceutical preparation
date
topical use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69711588T
Other languages
English (en)
Other versions
DE69711588T2 (de
Inventor
Luca Giorgetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Errekappa Eurotherapici SpA
Original Assignee
Errekappa Eurotherapici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Errekappa Eurotherapici SpA filed Critical Errekappa Eurotherapici SpA
Application granted granted Critical
Publication of DE69711588D1 publication Critical patent/DE69711588D1/de
Publication of DE69711588T2 publication Critical patent/DE69711588T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69711588T 1996-07-05 1997-07-02 Nimesulid enthaltende pharmazeutische zubereitung zur topischen anwendung Expired - Fee Related DE69711588T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96RM000480A IT1291278B1 (it) 1996-07-05 1996-07-05 Preparazione farmaceutica a base di nimesulide per uso topico
PCT/IB1997/000816 WO1998001124A2 (en) 1996-07-05 1997-07-02 Pharmaceutical preparation containing nimesulide for topical use

Publications (2)

Publication Number Publication Date
DE69711588D1 true DE69711588D1 (de) 2002-05-08
DE69711588T2 DE69711588T2 (de) 2002-10-31

Family

ID=11404325

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69711588T Expired - Fee Related DE69711588T2 (de) 1996-07-05 1997-07-02 Nimesulid enthaltende pharmazeutische zubereitung zur topischen anwendung

Country Status (13)

Country Link
US (1) US5998480A (de)
EP (1) EP0853476B1 (de)
JP (1) JPH11512116A (de)
KR (1) KR19990044280A (de)
CN (1) CN1199335A (de)
AT (1) ATE215367T1 (de)
CA (1) CA2231118C (de)
DE (1) DE69711588T2 (de)
DK (1) DK0853476T5 (de)
ES (1) ES2175419T3 (de)
IT (1) IT1291278B1 (de)
PT (1) PT853476E (de)
WO (1) WO1998001124A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1289973B1 (it) * 1997-02-25 1998-10-19 Helsinn Healthcare Sa Sistemi gelificati di nimesulide per uso topico
IT1291895B1 (it) 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
WO2000072884A1 (en) * 1999-05-31 2000-12-07 Dinesh Shantilal Patel A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide
EP1172101A1 (de) * 2000-06-20 2002-01-16 Helsinn Healthcare S.A. Verwendung von Nimesulfid zur Behandlung von Psoriasis und psoriatischer Arthritis
IT1318588B1 (it) * 2000-06-20 2003-08-27 Helsinn Healthcare Sa Uso della nimesulide nel trattamento di patologie dermatologiche.
KR100752990B1 (ko) * 2006-08-02 2007-08-30 주식회사 대웅 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물
TR200906775A1 (tr) * 2009-09-02 2011-03-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Nimesulid ve kas gevşetici kombinasyonları
WO2014125085A1 (en) 2013-02-15 2014-08-21 Sanovel Ilac Sanayi Ve Ticaret A.S. Oral pharmaceutical formulations comprising nimesulide and thiocolchicoside

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206496A1 (es) * 1972-07-03 1976-07-30 Riker Laboratories Inc Procedimiento para la preparacion de 2-fenoxi-4-nitro-alquil o haloalquilsulfonanilidas
US4933172A (en) * 1988-10-06 1990-06-12 Warner-Lambert Co. Method of and compositions for treating destructive periodontal disease
WO1991000043A1 (en) * 1989-06-28 1991-01-10 Black & Decker Inc. Toaster
ES2023552A6 (es) * 1990-05-22 1992-01-16 Leetrim Limited Procedimiento para la preparacion de compuestos de inclusion de nimesulida con ciclodextrina.
IT1251838B (it) * 1991-09-20 1995-05-26 Lpb Ist Farm Uso della nimesulide nel trattamento della cataratta
IL106035A0 (en) * 1992-06-24 1993-10-20 Skyview Cooling Co Pest eradicating composition and methods for reducing pests on growing plants utilizing the same
WO1996009812A1 (en) * 1994-09-27 1996-04-04 Rijksuniversiteit Leiden Phospholipid- and cholesterol-free aqueous composition for topical application to the skin
US5837735A (en) * 1994-10-05 1998-11-17 Helsinn Healthcare S.A. Antiinflammatory agent for external use
US5763422A (en) * 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
HUP9601442A3 (en) * 1995-07-25 1999-03-29 Panacea Biotec Ltd Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
US5814659A (en) * 1996-04-23 1998-09-29 Dtr Dermal Therapy (Barbados) Inc. Topical analgesic composition
HUP9601443A3 (en) * 1996-05-29 1999-03-29 Panacea Biotec Ltd Injectable analgetic pharmaceutical compositions for intramuscular use containing nimesulid, and process for producing them
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
IT1286496B1 (it) * 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria

Also Published As

Publication number Publication date
ITRM960480A0 (de) 1996-07-05
PT853476E (pt) 2002-08-30
DE69711588T2 (de) 2002-10-31
ES2175419T3 (es) 2002-11-16
US5998480A (en) 1999-12-07
WO1998001124A2 (en) 1998-01-15
ATE215367T1 (de) 2002-04-15
ITRM960480A1 (it) 1998-01-05
CA2231118A1 (en) 1998-01-15
KR19990044280A (ko) 1999-06-25
CA2231118C (en) 2001-09-18
IT1291278B1 (it) 1999-01-07
EP0853476B1 (de) 2002-04-03
DK0853476T5 (da) 2002-10-07
EP0853476A2 (de) 1998-07-22
CN1199335A (zh) 1998-11-18
WO1998001124A3 (en) 1998-02-19
DK0853476T3 (da) 2002-07-29
JPH11512116A (ja) 1999-10-19

Similar Documents

Publication Publication Date Title
ATE495748T1 (de) Parasiticide formulierung und methode zur herstellung dieser formulierung
BR0009770A (pt) Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma
DK0776202T3 (da) Liposomalt indkapslet taxol, dets fremstilling af dets anvendelse
AR024233A1 (es) Compuestos moduladores de ccr5, composiciones farmaceuticas, su uso en medicina.
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
BR0215052A (pt) Composições acaricidas e métodos
IL114447A0 (en) Multiple unit pharmaceutical preparation
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
ES2179910T3 (es) Modificacion cristalina del cdch, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
EA200100154A1 (ru) Бензоциклогептены, способ их получения, содержащие их фармацевтические препараты и их применение для получения лекарственных средств
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
TR200401603T4 (tr) D vitamini benzerleri
ATE78812T1 (de) Diarylverbindungen als antiatherosklerotische mittel.
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
HUP0003840A2 (hu) Szabályozott hatóanyagleadású gyógyászati készítmények
DE69711588T2 (de) Nimesulid enthaltende pharmazeutische zubereitung zur topischen anwendung
HUP0004375A2 (hu) Azelainsavat tartalmazó kompozíció
HUP0002346A1 (hu) Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény
ES2090703T3 (es) Medicamento agudo que contiene flurbiprofeno y su empleo.
WO1999050239A3 (fr) Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
SE9604752D0 (sv) Formulation and use
MX9302986A (es) Medicamento que contiene metrifonato y procedimiento para su preparacion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee